1.
Marlene Troch, Constanze Jonak, Leonhard Müllauer, Andreas Püspök, Michael Formanek, Wolfgang Hauff, Christoph C. Zielinski, Andreas Chott, Markus Raderer. A phase II study of bortezomib in patients with MALT lymphoma. haematol [Internet]. 2009May1 [cited 2022Sep.26];94(5):738-42. Available from: https://haematologica.org/article/view/5255